Search results
Results from the WOW.Com Content Network
Fucoidan is a long chain sulfated polysaccharide found in various species of brown algae.Commercially available fucoidan is commonly extracted from the seaweed species Fucus vesiculosus (), Cladosiphon okamuranus, Laminaria japonica (kombu, sugar kelp) and Undaria pinnatifida ().
Caulerpa lentillifera or sea grape is a species of ulvophyte green algae from coastal regions in the Asia-Pacific.This seaweed is one of the favored species of edible Caulerpa due to its soft and succulent texture.
Chaparral (or Larrea tridentata) – a plant used to make a herbal remedy which is sold as cancer treatment. Cancer Research UK state that: "We don't recommend that you take chaparral to treat or prevent any type of cancer." [67] Chlorella – a type of algae promoted for its health-giving properties, including a claimed ability to treat cancer ...
For premium support please call: 800-290-4726 more ways to reach us
Iodine deficiency is a lack of the trace element iodine, an essential nutrient in the diet.It may result in metabolic problems such as goiter, sometimes as an endemic goiter as well as congenital iodine deficiency syndrome due to untreated congenital hypothyroidism, which results in developmental delays and other health problems.
On the observation that Japanese women who consume iodine-rich seaweed have a relatively low rate of breast cancer, iodine is suggested as a protection against breast cancer. [64] [65] Iodine is known to induce apoptosis in breast cancer cells. [66] Laboratory evidence has demonstrated an effect of iodine on breast cancer that is in part ...
In 1811, Bernard Courtois isolated iodine from seaweed while in 1820 Jean-Francois Coindet linked iodine intake to goiter size. [5] It initially came into use as a disinfectant and a treatment for goiter. [6] [7] The following forms of iodine are found on the World Health Organization's List of Essential Medicines: [8]
Most alternative cancer treatments have not been tested in proper clinical trials. Among studies that have been published, the quality is often poor. A 2006 review of 196 clinical trials that studied unconventional cancer treatments found a lack of early-phase testing, little rationale for dosing regimens, and poor statistical analyses. [11]